leisure time -WSS

leisure time

author：focus 2025-09-05 13:33:00 - browse：768

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

WSS

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Listen: BridgeBio's big week & Lilly's Alzheimer's data

'The View' co

Hey, doctors: Don't be no

Akili, maker of video game for ADHD, to be acquired for 34 million

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

knowledge

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Listen: BridgeBio's big week & Lilly's Alzheimer's data

BioMarin wins approval for gene therapy to treat hemophilia A

Do more moles mean more problems? Not so, says new study

At least 13 dead in Texas as scorching temps continue

Average age of first period drops to 11.9 years, study shows

Supreme Court strikes down use of affirmative action

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Continuity nursing helped my family in our darkest PICU moments

What is the Turing Test that determines if computers can think?

hotspot

Trump Organization, Michael Cohen agree to settle million

EMA weighs against approval for Mirati's lung cancer drug

Insmed lung disease drug hits target in key Phase 3 trial

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Addiction doctors spar with methadone clinics over legislation

New chief aims to remake Sanofi Genzyme

hotspot

leisure time

knowledge

entertainment